Mirum Pharmaceuticals, Inc. (MIRM) Insider Trading

Name: Mirum Pharmaceuticals, Inc. (MIRM) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 7, 2026): Christopher Peetz (CHIEF EXECUTIVE OFFICER): Exercise/Conversion of 5,305 shares, $101.8K.

Get alerted when insiders trade MIRM

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta